Synergy between the clavanins as a weapon against multidrug-resistant Enterobacter cloacae
- PMID: 38911167
- PMCID: PMC11187565
- DOI: 10.1039/d4md00070f
Synergy between the clavanins as a weapon against multidrug-resistant Enterobacter cloacae
Abstract
Finding new antibiotics that can act synergistically with each other offers many benefits such as lower dosages used for each drug, improved pathogen clearance, and ability to act against multi-drug resistant strains. In this study, six peptides isolated from the tunicate Styela clava were evaluated for their synergistic interaction using the checkerboard assay and the time kill kinetics assay. Using two different tests, we report synergy between clavanin D and clavaspirin in both tests and synergy between clavanin A and B only in the checkerboard test when used against the multidrug resistant E. cloacae 0136. This work demonstrates the possible cooperativity between homologous AMPs from a single organism and the advantage of using two susceptibility tests instead of one when testing synergistic combinations.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
There are no conflicts to declare.
Figures





References
-
- Centers for Disease Control and Prevention (U.S.), Antibiotic resistance threats in the United States, 2019, Centers for Disease Control and Prevention (U.S.), 2019
LinkOut - more resources
Full Text Sources